Compare Adaptive Biotechnologies Corp (ADPT) vs Western Digital Corp (WDC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Western Digital Corp — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while Western Digital Corp trades at $545 (market cap $183.41B). The key difference: Western Digital Corp is far larger — about 55.1× Adaptive Biotechnologies Corp's market cap, and Western Digital Corp pays a 0.11% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | WDC | |
|---|---|---|
Market Cap | $3.33B | $183.41B |
Sector | Health | Technology |
52-Week High | $22.37 | $746.23 |
52-Week Low | $10.24 | $64.02 |
Enterprise Value | $3.19B | $181.75B |
Dividend Yield | — | 0.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADPT trades at $20.82, down 1.75% today, with a bullish technical signal from moving averages and a consensus analyst price target of $20.40. The company announced a strategic separation of its MRD and Immune Medicine businesses in June 2026, alongside a $300 million convertible notes offering to enhance financial flexibility. Revenue grew to $277 million in 2025, though net losses persist at -$59.50 million, with improving margins and cash flow trends showing net positive cash generation of $22.37 million.
Outlook remains cautiously optimistic as the business split aims to unlock value, but execution risks and sustained profitability challenges pose headwinds. Analysts are predominantly bullish (64.71% buy ratings), citing growth in the clonoSEQ MRD segment, yet the stock faces volatility from high valuation multiples and insider selling activity.
Western Digital (WDC) trades at $532.1, down 1.28% amid a sector-wide memory stock sell-off. The stock shows strong fundamentals with three consecutive quarterly earnings beats and a net income margin of 55.07% in 2025. Analyst consensus is strongly bullish with a $607.46 price target, though technical indicators signal near-term bearish pressure with support at $523.
Outlook remains positive driven by AI and data center demand, but volatility from memory pricing cycles and competitive pressures pose risks. Upside depends on continued execution and sector momentum, with the current dip potentially offering entry for growth-oriented investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
